Arkolith/Insider Trading/SCPH/Form 4

Nokes Rachael

See RemarksscPharmaceuticals Inc. (SCPH) · full profile →Form 4 · filed Jan 23, 2023
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 19, 2023Grant(A)12K$6.14$72K22K
Feb 25, 2021Tax withholding(F)2K$7.27$14K10K
Feb 25, 2020Tax withholding(F)2K$10.09$20K12K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 19, 2023Grant(A)18K—$018K

Transaction Codes

A
Grant / award
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000899243-23-002425) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML